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A B S T R A C T
Objective: Mutations in the GJB2 gene are a major cause of autosomal recessive non-syndromic HL (ARNSHL) in
many populations. Previous studies have estimated the average frequency of GJB2 mutations to be between 16
and 18% in Iran, but would vary among diﬀerent ethnic groups. Here, we have taken together and reviewed
results from our three previous publications and data from search other published mutation reports to provide a
comprehensive collection of data for GJB2 mutations and HL in the south of Iran.
Methods: In all, 447 unrelated families were included and analyzed for the prevalence and type of the GJB2 gene
mutations.
Results: Totally, the frequency of GJB2 mutations was found to be 11.5% in the southern provinces studied
which is signiﬁcantly lower than that identiﬁed in Northern populations of Iran, and also a southwest to
southeast Iranian gradient in the frequency of GJB2 mutations is suggested.
Conclusions: This study highlights the importance of establishing prevalence, based on the local population for
screening and diagnostic programs of live births in Iran.
1. Introduction
Hearing loss (HL) is a complex disorder and accounts for 0.2% of
newborns worldwide (http://hearing.screening.nhs.uk/nationalprog).
Approximately 50–70% of HL being related to genetic causes. It is es-
timated that 70% of cases includes non-syndromic forms (NSHL), where
the hearing deﬁcit is the only sign [1]. Although all Mendelian in-
heritance patterns have been observed for pre lingual HL, Autosomal
recessive mode of inheritance (ARNSHL) makes up 80% of the NSHL
cases [2]. ARNSHL is highly heterogeneous, for which over 100 mapped
loci are known to be involved (http://hereditaryhearingloss.org).
Nevertheless, a single locus, DFNB1 (13q11-12) which contains GJB2
(NM_004004.5) and GJB6 (NM_001110219.2) genes, accounts for about
50% of the etiology in many Western populations [3,4]. GJB2 encodes
the connexin-26 (Cx26) gap-junction channel protein that underlies
both intercellular communication among supporting cells and home-
ostasis of the cochlear ﬂuids, endolymph and perilymph [5]. The gene
has a simple genomic structure with only two exons, with exon 1 being
untranslated. To date, more than 100 pathogenic mutations in the GJB2
gene and over 4 pathogenic deletions, including gross del(GJB6-
D13S1830) and del(GJB6-D13S1854) in the GJB6 gene have been
identiﬁed resulting in ARNSHL [5]. The prevalence of GJB2 mutations
varies among diﬀerent populations [6–9]. In Caucasians, c.35delG is
the most common mutation with the carrier frequency as high as 2–4%
[10]. However, c.167delT, c.235delC and c.71G > A are the most
frequent mutations in the Ashkenazi Jewish [11], Japanese [12] and
Indians [13], respectively.
Since the last decade, a series of studies have been conducted on the
Iranian population in order to identify the mutation spectrum and
prevalence of GJB2 mutations [14–20]. The diverse ethnicities, coupled
with the high rate of consanguinity rates (38% in average) [21] tend to
change mutation frequencies among ethnic groups. Therefore, for ac-
curate and eﬀective genetic counseling, studying certain ethnic groups
is of high importance [22]. In this paper, we summarized the published
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data on the frequency and proﬁle of the GJB2 gene mutations in 447
unrelated families from 5 diﬀerent provinces; namely Khuzestan, Sistan
& Baluchestan, Hormozgan, Fars and Bushehr in the south Iran com-
pared to other parts of this country.
2. Materials and methods
This study included results from our four previous publications on
GJB2-Related HL in Iran. We also performed a PubMed, Google Scholar,
and Web of Science search using search terms “GJB2 mutations” or
“connexin 26” and “Iran”. Among search results, we limited the search
to humans that held information on molecular genetics of HL. Studies
were included when fulﬁlling the following three criteria: (1) perfor-
mance on non-syndromic hearing loss subjects, (2) described the eth-
nicity of tested subjects and (3) detected all the GJB2mutations. Studies
were excluded if hearing loss was a result of environmental factors such
as infection, trauma, rubella, meningitis, mumps, ototoxic drugs and
premature birth. Research data including 447 unrelated deaf families of
southern provinces were collected. The frequency and mutation type of
447 deaf families were extracted from relevant studies and categorized,
corresponding with geographical boundaries. In silico analyses were
also performed by available software tools to predict the pathogenicity
of the mutations.
3. Results
Data from 447 unrelated families were gathered for analysis (Fig. 1).
The groups studied consisted of 50 family from Fars province (11.2%),
73 family from Khuzestan (16.5%), 184 family from Sistan & Ba-
luchestan (41.2%), 121 family from Hormozgan (27%) and 19 family
from Bushehr province (4.1%). The GJB2 mutation allele frequencies of
each studied group included 13, 15.7, 6.2, 3.7, 4.3% of total studied
families (n=447) of Fars, Bushehr, Khuzestan, Hormozgan and Sistan
& Baluchestan provinces, respectively.
Totally, 18 diﬀerent variants were identiﬁed, 13 of which were re-
ported as pathogenic. These include: c.35delG, 23+1G > A,
c.167delT, c.238G > A, c.71G > A, c.279G > A, c.445G > A,
c.507A > C, c.592G > A, c. 82C > A, c.336G > T, c.163A > G,
c.100A > G. In the studied populations, c.35delG was the most
frequent mutation. The highest rate of c.35delG mutation was detected
in Fars province with an allele frequency of 7% while we did not ﬁnd
any c.35delG mutation in Sistan & Baluchestan. Fig. 2 shows the dis-
tribution of the identiﬁed mutations in the schematic structure of Cx26.
A speciﬁc combination of GJB2 mutations types and frequencies were
found in diﬀerent studied provinces (Table 1). A higher GJB2mutations
diversity (7 type) was observed in Fars province while the lowest di-
versity identiﬁed in Khuzestan (1 type).
4. Discussion
This study reviews the prevalence and type of the GJB2 gene mu-
tations by means of a literature review and compares 447 deaf families
from 5 provinces in the south of Iran. The genetic epidemiology of
ARNSHL is very diﬀerent among populations even from neighboring
countries, because of subtle variations in their ethnic composition and
because of founder eﬀects [23]. The Iranian population is composed of
many diﬀerent ethnic groups, so it is important to discuss ethnic spe-
ciﬁc data [24]. Here, the most consistent ﬁnding was the reduction for
GJB2 mutations frequency of southwest to southeast Iran. Conﬁrming
the northwest to southeast GJB2 HL gradient throughout Iran, our data
indicated a southwest to southeast gradient among Iranian populations
with a GJB2mutations frequency of 20% for Fars province and 7.7% for
Sistan & Baluchestan province. The results obtained from other studies
have shown that the mutation frequency of GJB2 varies between 0 and
35% among diﬀerent parts of Iran [25]. The study performed by Naj-
mabadi et al. [26] on 664 ARNSHL families indicated that GJB2 related
HL account for 16.7% in Iranian population and c.35delG mutation was
the most common GJB2 mutation (∼63.1% of the identiﬁed GJB2
mutations). They also found the highest percentage of GJB2 related HL
in the north and northwest regions (north 38.3% and northwest 22.2%)
of Iran has been explained by the founder eﬀect [27]. In another cohort
study, Hashemzadeh et al. [28] showed that the frequency of GJB2
mutations to be 27.5% in the north and Northwest provinces of the Iran,
while it was less than 4% in the Southeast region. The observed
northwest to southeast GJB2 HL gradient is further supported by data
speciﬁc to the southeast and northwest Iran, where the populations are
related to the neighboring Oman and Turkey [29,30]. Bonyadi et al.
[31] presented that GJB2 mutations were responsible for about 28% of
Fig. 1. Schematic structure, domains and distribution of mutations of the Cx-26 protein in this study. The most common mutations in south Iran (c.35delG,
c.71G > A and c.167delT) are underlined.
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ARNSHL in the Iranian Azeri Turkish patients (Northwest Iran) and
c.35delG was the most prevalent mutation accounting for 64.5% of
GJB2 mutations, which is similar to the reported results of the Turkish
population [32]. Our results showed that the contribution of GJB2
mutations to ARNSHL is 3.7 and 4.3% in Hormozgan and Sistan &
Baluchestan provinces, respectively. This lower rate of c.35delG mu-
tation has been reported in Pakistan population (6.1%) [33]. This
ﬁnding is comparable to those reported previously by Najmabadi et al.
[26]. They reported the lowest percentage of GJB2-related HL in the
south of Iran.
Fig. 2. The prevalence of GJB2-related mutations in diﬀerent region of Iran (northwest 22–27% [26,28], north 27–38% [26,28], center 13–15% [25,26]). Five
southen provinces (Khuzestan, Sistan & Baluchestan, Hormozgan, Fars and Bushehr) were shown in the map.
Table 1
GJB2 mutations, their frequencies and in silico analyses in ﬁve provinces of Iran. The pathogenic mutations and benign variants were separated in the two parts. The
mutations were arranged in numerical order. T:Truncated Protein, NT: Non-Truncated Protein, NA: Not Available.
Mutations No(%) mutation type classiﬁcation Functional eﬀect
Fars Khuzestan Hormozgan Hormozgan Sistan $ Baluch. Sistan $ Baluch. Bushehr Mutation Taster SIFT
c.29delT 0 0 0 2(6.25) 0 0 0 Frame shift T Disease causing NA
c.35delG 7(7) 9 (6.16) 3 (1.42) 0 0 0 4 (10.5) Frame shift T Disease causing NA
c.71G > A 0 0 2 (0.95) 0 2 (1.19) 10 (5) 0 Nonsense T Disease causing Damaging
c.100A > G 1 (1) 0 0 0 0 0 0 Missense NT Disease causing Damaging
c.167delT 0 0 0 0 0 2 (1) 1 (2.63) Frame shift T Disease causing NA
c.82C > A 1 (1) 0 0 0 0 0 0 Missense NT Disease causing Damaging
c.238G > A 0 0 0 2(6.25) 0 0 0 Missense NT Disease causing Damaging
c.279G > A 0 0 0 0 0 1 (0.5) 0 Missense NT Disease causing Damaging
c.365A > T 1 (1) 0 0 0 0 1 (0.5) 0 Missense NT Disease causing Damaging
c.445G > A 1 (1) 0 0 0 0 0 0 Missense NT Disease causing Damaging
c.507A > C 1 (1) 0 0 0 0 0 0 Missense NT Disease causing Damaging
c.592G > A 1 (1) 0 0 0 0 0 0 Missense NT Disease causing Damaging
23+1G > A 0 0 0 0 0 0 1 (2.63) Splice site T Disease causing NA
c.79G > A 1 (1) 0 6 (2.85) 0 1 (0.59) 0 0 Missense NT polymorphism Tolerated
c.380G > A 0 0 4 (1.9) 0 2 (1.19) 4 (2) 1 (2.63) Missense NT polymorphism Benign
c.457G > A 6 (6) 0 3 (1.42) 0 8 (4.76) 0 0 Missense NT polymorphism Benign
c.341A > G 0 1 (0.64) 0 0 1 (0.59) 0 0 Missense NT polymorphism Benign
c.476G > A 0 1 (0.64) 0 0 0 0 0 Missense NT polymorphism Benign
Normal 81 135 192 28 154 182 32
Total 100 146 210 32 168 200 38
References [47] [48] [35] [49] [28] [34] [25]
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Another ﬁnding of this study was the mutation spectrum of the
southeast, which was diﬀerent from those of the rest Iranian population
regions. Naghavi et al. [34] screened 100 ARNSHL families from Sistan
& Baluchestan province in Southeast Iran for GJB2 mutations. They
reported that GJB2 mutations were detected in 7% of the ARNSHL fa-
milies studied. Interestingly, c.71G > A was the most frequent GJB2
mutation, while c.35delG was absent in this ethnicity. Results obtained
for the carrier frequency of c.71G > A mutation was 40–55% in Ba-
luchi population whereas 1.45% in the rest Iranian groups. However,
the Baluchi population is ethnically distinct from the rest of Iran. Be-
sides, 16 unrelated ARNSHL families from Hormozgan province (south
of Iran) were reviewed, with a frequency of 12.5% for GJB2 gene mu-
tations. We didn't ﬁnd c.35delG mutation in this population. In another
study performed by Sasanfar et al. [35] on 105 ARNSHL families from
Hormozgan province showed that GJB2 related HL account for 2.3% in
this population and the role of c.35delG mutation was only∼17.6% of
the identiﬁed GJB2 variants. This low rate of 35delG mutation has been
reported in some populations of Pakistani and Omani families [30,36].
In the study performed by Koohiyan et al. [37] on 40 ARNSHL fa-
milies indicated that GJB2 related HL account for 22.5% in center Iran.
This is about ﬁve times the frequency of GJB2 mutations in Sistan &
Baluchestan province. On the basis of these results and our previous
studies [28], it can be concluded that the frequency of c.35delG de-
creases gradually northwest to center and center to southeast (Fig. 2).
In our studied populations, the most common mutation was
c.35delG, accounting for 38.0% of GJB2 mutations. The c.35delG mu-
tation is found to be the most common mutation in many world po-
pulations as well as many countries in the Middle East. It is mostly
presented in the Turkey, north and northwest of Iran and it is much less
present in southeast of Iran, Pakistan and Arabic countries located in
the southern part of Persian Gulf [32,36,38,39]. The analysis of the
geographical distribution of mutations located in GJB2 gene showed
more allelic heterogeneity in the north and center compared to the
south of Iran [28]. The three most common mutations of the GJB2 gene
in the south of Iran, namely, c.35delG, c.71G > A and c.167delT are
responsible for ∼75% of all pathogenic alleles in the south Iran
(Table 1). The c.35delG mutation, which is the most common (up to
85%) among northern regions [28], makes up for 45% of GJB2 muta-
tions in the southern populations. The c.71G > A and c.167delT are
the second and third common mutations, with a sum of 27.5% and 5.9%
of all pathogenic alleles.
The p.Trp24*, a nonsense mutation is the result of c.71G > A
transition, changing TGG codon for Trp residue to a stop codon, which
leads to a truncated protein with probably no functional properties. In
silico analyses are consistent with the pathogenicity of the mutation
(Table 1). The c.71G > A mutation is the most common mutation in
Slovak Romany, Pakistan and Indian populations [40–42]. The rate of
carriers of c.71G > A mutation is 4.08% in Pakistan population [36].
This mutation shows a high frequency in Baluchi group (southeast Iran)
and accounts for 80% of the mutant alleles in this ethnicity, where the
population is related to the neighboring Pakistan [34].
The p.Arg127His, substituting arginine with histidine residue, is the
result of c.380G > A transition. Although some researchers have
concluded that c.380G > A is only a polymorphism without any as-
sociation with HL (http://www.crg.es/deafness/). Our In silico analyses
also conﬁrm it; in contrast of mutation taster software, PolyPhen de-
tected it as a benign mutation. Interestingly, c.380G > A is homo-
geneously distributed throughout Iran, arginine 127 might be a hotspot
point [43]. This review showed a particular combination of GJB2 mu-
tations diversity in diﬀerent provinces of south Iran. A higher GJB2
mutations diversity (7 type) was detected in Fars province, suggesting
the co-existence of several diﬀerent ethnic groups and immigrations to
big city such as Shiraz during last century.
More recently, researchers have shown that mutations of GJB2 can
function in a di genic manner with the GJB6 genes [44]. Hence, mu-
tation analysis of this gene should be considered in GJB2 heterozygotes.
Hashemzadeh et al. showed that more than 30% of patients were het-
erozygous carrier in south and southeast Iran [35]. Further investiga-
tion is needed to detect the genetic cause of HL in the patients with
mono allelic GJB2 mutations [45,46].
5. Conclusions
The critical and speciﬁc position of Iran and the existence of various
ethnic groups with diﬀerent cultures suggest the high heterogeneity
throughout Iran but speciﬁc intra ethnic traditions such as intragroup
marriages may give rise to a high homogeneity in some loci and mu-
tations within groups. GJB2 mutations are responsible for ∼11.5% of
deaf families in south Iran [28,34,47] that is less than that in northwest
region (22–27%) [26,28] showing migration pathway from west to east
through the silk route. Regarding the GJB2 mutations, c.35delG is the
most common mutation that is tested ﬁrst. In studied populations,
speciﬁc mutations are common, which are detected in each group; for
example, the frequency of the c.71G > A shows a high rate in Sistan &
Baluchestan provinces, accounting for 75% of the mutant alleles. This
study highlights the importance of establishing incidence, based on the
local population of speciﬁc and common GJB2 mutations in designing
screening strategies.
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